How much funding has bitBiome raised?

bitBiome has raised $28.8M in total funding, most recently a extension round round.

Who are bitBiome's investors?

bitBiome's investors include IT-Farm, IQT, University of Tokyo Edge Capital Partners.

Where is bitBiome headquartered?

bitBiome is headquartered in Tokyo, Japan.

What industry is bitBiome in?

bitBiome operates in Biotech, Genomics, Life Sciences, Synthetic Biology.

bitBiome

The single-cell microbe company

Tokyo, Japan · Founded 2018 · $28.8M raised

Headquarters: Tokyo
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: bitbiome.co.jp
Total Funding: $28.8M
Last Round: $22.2M Extension RoundMay 2026
Rounds: 3

About

bitBiome is a Tokyo-based biotechnology company founded in 2018, spun out of Waseda University research by founder Masahito Hosokawa. The company has built proprietary microbial single-cell microfluidic sequencing technology (bit-MAP®) and a large microbial sequence database (bit-GEM) containing over 1.3 billion sequences. bitBiome offers three primary service lines: enzyme discovery and engineering, synthetic biology applications, and microbiome sequencing analysis. The company's technology unlocks the potential of previously unculturable microbes and serves pharmaceutical, food, materials, and life science customers. Partners include Ajinomoto, Tokyo Ohka Kogyo, and Twist Bioscience. The company employs approximately 45 people.

Summary

bitBiome is a Biotech company based in Tokyo, Japan, founded in 2018. It has raised $28.8M in total across 3 rounds, most recently a $22.2M Extension Round round in May 2026. Investors include IT-Farm, IQT and University of Tokyo Edge Capital Partners.

LinkedIn X (Twitter)